SGLT2 inhibitor for secondary prevention in acute myocardial infarction patients with diabetes mellitus

被引：0
|
作者：
Kim, D. B. [1 ]
Kim, H. Y. [1 ]
机构：
[1] Catholic Univ Korea, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Impact of SGLT2 Inhibitors on Left Ventricular Remodeling in Diabetic Patients with Acute Myocardial Infarction
    Wan, Jun
    Xu, Feng
    Zuo, Heping
    Jiang, Xin
    Wang, Yulin
    Jiang, Yang
    Chen, Cai
    Yin, Chunlin
    Cheng, Jinglin
    Li, He
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 29
  • [32] Empagliflozin, an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus: A Review of the Evidence
    White, John R., Jr.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (05) : 582 - 598
  • [33] SGLT2 Inhibitors for the Primary and Secondary Prevention
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (01): : 47 - 49
  • [34] Positive effects of SGLT2 inhibitors on cardiac markers after acute myocardial infarction are similar in patients with and without type 2 diabetes
    Aziz, Faisal
    Oulhaj, Abderrahim
    Tripolt, Norbert
    Pferschy, Peter
    von-Lewinski, Dirk
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S752 - S753
  • [35] Comparison of SGLT2 inhibitors versus DPP-4 inhibitors as combination with metformin in patients with acute myocardial infarction with diabetes
    Lyu, Y.
    Oh, S.
    Kim, J.
    Jeong, M.
    Kim, S.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S474 - S475
  • [36] RENAL EFFECTS AND NEPHROPROTECTION INDUCED BY THE SGLT2 INHIBITOR EMPAGLIFLOZIN IN PATIENTS WITH DIABETES MELLITUS: A LITERATURE REVIEW
    Morales-Buenrostro, Luis E.
    Citlali Juarez-Comboni, Sonia
    Aldrete Velasco, Jorge
    Rodriguez Alcocer, Alma Nelly
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2017, 37 (01): : 48 - 61
  • [37] SGLT2 Inhibitors in Type 2 Diabetes Mellitus
    Ferrannini, Giulia
    Savarese, Gianluigi
    Cosentino, Francesco
    HEART FAILURE CLINICS, 2022, 18 (04) : 551 - 559
  • [38] LUSEOGLIFLOZIN SGLT2 Inhibitor Treatment of Diabetes
    Tiwari, A.
    DRUGS OF THE FUTURE, 2012, 37 (09) : 637 - 643
  • [39] THE SGLT2 INHIBITOR DAPAGLIFLOZIN IMPROVES ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE STUDY
    Cannarella, Rossella
    Condorelli, Rosita A. Angela
    Leanza, Claudia
    Garofalo, Vincenzo
    Lundy, Scott
    Calogero, Aldo E.
    La Vignera, Sandro
    FERTILITY AND STERILITY, 2023, 120 (04) : E245 - E246
  • [40] Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
    Yshai Yavin
    Traci A. Mansfield
    Agata Ptaszynska
    Kristina Johnsson
    Shamik Parikh
    Eva Johnsson
    Diabetes Therapy, 2016, 7 : 125 - 137
12345